Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution

Area of Science:

• Cardiovascular Pharmacology
• Transplantation Medicine
• Pulmonary Physiology

Background:

• Euro-Collins solution (ECS) is standard for lung preservation but can induce pulmonary vasoconstriction.
• High potassium content in ECS causes vasoconstriction above 20°C.
• Prostaglandin E1 and prostacyclin are commonly used pretreatments.

Purpose of the Study:

• To compare the efficacy of five drugs in counteracting ECS-induced pulmonary vasoconstriction in porcine arteries.
• To identify optimal pretreatment strategies for lung preservation.

Main Methods:

• Porcine pulmonary arteries were used to test five drugs as pretreatments and perfusates.
• Vasoconstrictive effects of ECS were measured.
• Drug efficacy was quantified by the reduction in vasoconstriction.

Main Results:

• Papaverine reduced vasoconstriction by 92%, nifedipine by 62%.
• Daltroban and prostaglandin E1 showed minimal reduction (15% and 12%).
• Prostacyclin enhanced vasoconstriction by 37%; papaverine (10⁻⁴ mol/L) and nifedipine (10⁻⁶.⁵ mol/L) combination abolished vasoconstriction without affecting endothelial function.

Conclusions:

• Papaverine and nifedipine are effective in preventing ECS-induced pulmonary vasoconstriction.
• Prostaglandin E1 and prostacyclin are not effective for this purpose.
• Combined papaverine and nifedipine offer a promising strategy for lung preservation in transplantation.